Business
Planet Labs PBC Stock Soars 25% on Record Backlog and Upbeat Guidance: Shares Hit All-Time High
Planet Labs PBC (NYSE: PL), the San Francisco-based Earth imaging and geospatial analytics company, saw its shares surge more than 25% in heavy trading on March 20, 2026, closing at a record high as investors reacted enthusiastically to stronger-than-expected fourth-quarter results, a massive backlog expansion and optimistic fiscal 2027 projections.

Planet Labs PBC closed at $33.83, up $6.87 or 25.48% from the previous close of $26.96. The stock opened at $33.55, reached an intraday high of $36.28 — marking a new 52-week and all-time peak — and dipped to a low of $32.26 before paring some gains. Volume exploded to more than 63.7 million shares, nearly five times the average daily trading volume, reflecting intense institutional and retail interest following the March 19 earnings release.
The explosive move came after Planet reported fiscal fourth-quarter revenue of $86.8 million for the period ended January 31, 2026 — a 41% year-over-year increase and well above analyst consensus expectations around $78–$80 million. Full fiscal 2026 revenue reached a record $308 million (or approximately $307.7 million in some references), up about 26% from the prior year. The company also achieved its first full fiscal year of non-GAAP profitability, posting adjusted EBITDA of $15.5 million and positive free cash flow of $53 million.
In the fourth quarter alone, adjusted EBITDA came in at $2.3 million, marking the fifth consecutive profitable quarter on that metric. Non-GAAP gross margin stood at 57–59% for the period and year, demonstrating improving operational leverage as the company scales its satellite constellation and data services.
A key catalyst was the dramatic growth in backlog, which swelled 79% year-over-year to approximately $900 million. This figure provides strong revenue visibility, particularly from defense, intelligence and government contracts that have surged 50% in demand. Executives highlighted the shift toward higher-value, multi-year deals in national security and enterprise sectors, reducing reliance on shorter-cycle commercial sales.
Guidance for fiscal 2027 further fueled the rally. Planet projected revenue between $415 million and $440 million — implying midpoint growth of about 39% — and adjusted EBITDA between breakeven and $10 million. The outlook reflects confidence in backlog conversion and continued momentum in defense spending amid global geopolitical tensions.
Wall Street responded swiftly with a barrage of upgrades and price target increases. Cantor Fitzgerald raised its target to $40 from $20, Wedbush to $40 from $30, Needham to $40 from $35, Northland to $33 from $28, and Clear Street to $34 from $29. Multiple analysts maintained Buy ratings, citing the company’s positioning in the booming commercial satellite imagery market, partnerships like the recent NVIDIA collaboration for a GPU-native AI engine, and selection as a prime contractor under a massive $151 billion SHIELD IDIQ defense vehicle announced earlier in March.
The stock’s performance has been remarkable in 2026. Year-to-date gains now exceed 71%, while the one-year return stands at nearly 700% and the three-year return tops 877%. From a 52-week low of $2.79, PL has delivered extraordinary returns, driven by execution improvements, profitability milestones and sector tailwinds in space technology and geospatial intelligence.
Planet Labs operates the world’s largest constellation of Earth-imaging satellites, capturing daily global data used for agriculture, forestry, disaster response, climate monitoring and defense applications. Recent strategic moves include extending restrictions on Middle East imagery access to prevent misuse by adversaries, convening European and defense advisory boards, and advancing AI capabilities through collaborations.
Despite the euphoria, some analysts caution that the rapid run-up has pushed valuation metrics higher. The company remains unprofitable on a GAAP basis, with a negative price-to-earnings ratio around -43, though improving fundamentals and backlog support the premium. Market cap now exceeds $11.5 billion.
Investors will watch for sustained momentum as the company works toward full GAAP profitability and further backlog growth. With defense budgets rising and commercial adoption accelerating, Planet Labs appears well-positioned in the expanding space economy.
The March 20 surge underscores how earnings beats combined with forward-looking confidence can ignite explosive moves in growth-oriented tech stocks. As Planet Labs enters the next phase of its evolution — from satellite operator to planetary intelligence leader — market participants are betting heavily on continued execution and sector demand.
Business
US-Iran talks pause for now, disagreements remain

US-Iran talks pause for now, disagreements remain
Business
RBC Capital raises Williams Companies stock price target on power demand outlook

RBC Capital raises Williams Companies stock price target on power demand outlook
Business
Costa Rica receives first group of deported migrants under third-country agreement with US

Costa Rica receives first group of deported migrants under third-country agreement with US
Business
Islamabad on lockdown as high-stakes U.S.-Iran peace talks begin

Islamabad on lockdown as high-stakes U.S.-Iran peace talks begin
Business
Big screens, bigger fandom: BTS brings ‘ARIRANG’ tour to AMC theaters

Big screens, bigger fandom: BTS brings ‘ARIRANG’ tour to AMC theaters
Business
China would face ‘big problems’ if it ships arms to Iran, Trump warns

China would face ‘big problems’ if it ships arms to Iran, Trump warns
Business
RBC Capital cuts QXO stock price target on housing weakness

RBC Capital cuts QXO stock price target on housing weakness
Business
Doubleview Gold Is Acquisition-Ready
Doubleview Gold Is Acquisition-Ready
Business
Manhattan district attorney investigates sexual assault claims against Swalwell

Manhattan district attorney investigates sexual assault claims against Swalwell
Business
Canaccord raises Taysha Gene Therapies price target on trial progress

Canaccord raises Taysha Gene Therapies price target on trial progress
-
Business6 days agoThree Gulf funds agree to back Paramount’s $81 billion takeover of Warner, WSJ reports
-
Politics1 day agoUS brings back mandatory military draft registration
-
Fashion1 day agoWeekend Open Thread: Veronica Beard
-
Tech4 days agoHow Long Can You Drive With Expired Registration? What Florida Law Says
-
Business7 days agoNo Jackpot Winner, Prize to Climb to $231 Million
-
Fashion6 days agoMassimo Dutti Offers Inspiration for Your Summer Mood Board
-
Sports1 day agoMan United discover Nico Schlotterbeck transfer fee as defender reaches Dortmund agreement
-
Fashion4 days agoLet’s Discuss: DEI in 2026
-
Crypto World3 days agoCanary Capital Files SEC Registration for PEPE ETF
-
Business1 day agoTesla Model Y Tops China Auto Sales in March 2026 With 39,827 Registrations, Beating Cheaper EVs and Gas Cars
-
Crypto World3 days agoBitcoin recovers as US and Iran Agree a Ceasefire Deal
-
Politics2 days agoMalcolm In The Middle OG Turned Down ‘Buckets Of Money’ To Appear In Reboot
-
Business9 hours agoIreland Fuel Protests Enter Day 5 as Blockades Spark Shortages and Government Prepares Support Package
-
Business2 days agoOpenAI Halts Stargate UK Data Centre Project Over Energy Costs and Copyright Row
-
Tech6 days agoHaier is betting big that your next TV purchase will be one of these
-
Tech6 days agoGamer Restores the Original PlayStation Portal From Two Decades Ago
-
Tech6 days agoThe Xiaomi 17 Ultra has some impressive add-ons that make snapping photos really fun
-
Tech6 days agoSamsung just gave up on its own Messages app
-
Politics2 days agoLBC Presenter Mocks Trump Over Iran War Failures
-
Tech6 days agoSave $130 on the Samsung Galaxy Watch 8 Classic: rotating bezel, sleep coaching, and running coach for $369

You must be logged in to post a comment Login